Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Ott%2C+Patrick+A%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Ott%2C+Patrick+A%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Ott%2C+Patrick+A%22&type=Person&sort=year
PubPharm (272)
1
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma : Impact of Antibiotic Preconditioning on Microbiome and Immunity
enthalten in:
Cancer discovery
| 2024
von
Glitza, I.
|
Seo, Y.
|
Spencer, C.
| +27
Wird geladen...
2
Personalized Cancer Vaccines Directed against Tumor Mutations : Building Evidence from Mice to Humans
enthalten in:
Cancer research
| 2024
von
Fritsch, E.
|
Ott, P.
Wird geladen...
3
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2024
von
Schenk, K.
|
Deutsch, J.
|
Chandra, S.
| +23
Wird geladen...
4
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
enthalten in:
Journal for immunotherapy of cancer
| 2024
von
Khushalani, N.
|
Ott, P.
|
Ferris, R.
| +16
Wird geladen...
5
INDUCE-2 : A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors
enthalten in:
Cancer immunology, immunotherapy : CII
| 2024
von
Hilton, J.
|
Ott, P.
|
Hansen, A.
| +9
Wird geladen...
6
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors
enthalten in:
Cancer immunology immunotherapy
| 2024
von
Hilton, J.
|
Ott, P.
|
Hansen, A.
| +9
Wird geladen...
7
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
enthalten in:
Cancer immunology, immunotherapy : CII
| 2024
von
Baginska, J.
|
Nau, A.
|
Gomez Diaz, I.
| +19
Wird geladen...
8
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
enthalten in:
Cancer immunology immunotherapy
| 2024
von
Baginska, J.
|
Nau, A.
|
Gomez Diaz, I.
| +19
Wird geladen...
9
Precision cancer medicine : Concepts, current practice, and future developments
enthalten in:
Journal of internal medicine
| 2023
von
Edsjö, A.
|
Holmquist, L.
|
Geoerger, B.
| +16
Wird geladen...
10
A phase I/II study of LY3022855 with BRAF/MEK inhibition in patients with Melanoma
enthalten in:
Investigational new drugs
| 2023
von
Buchbinder, E.
|
Giobbie-Hurder, A.
|
Haq, R.
| +1
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
272
Aufsätze
216
E-Artikel
216
E-Ressourcen
56
Gedruckte Aufsätze
Zeitschriftentitel
24
Journal for ImmunoTherapy of Cancer
12
Investigational new drugs
12
Journal for immunotherapy of cancer
12
Journal of neuro-oncology
11
Cancer immunology immunotherapy
11
Journal of clinical oncology : official journal...
10
Clinical cancer research : an official journal ...
9
Cancer
9
Cancer immunology research
6
Cancer and metastasis reviews
5
Cancer immunology, immunotherapy : CII
5
Nature
5
The oncologist
4
Cancer cell
4
Cancer chemotherapy and pharmacology
4
Cancer discovery
4
Cellular immunology
4
Gastric cancer
4
International journal of radiation oncology, bi...
4
Kidney international
Alle anzeigen ...
weniger ...
Thema
157
Journal Article
69
Research Support, Non-U.S. Gov't
63
Melanoma
40
Research Support, N.I.H., Extramural
39
Immunotherapy
36
Ipilimumab
29
Multicenter Study
28
Antibodies, Monoclonal
28
Clinical Trial, Phase I
28
Nivolumab
25
Review
24
Antibodies, Monoclonal, Humanized
22
Antineoplastic Agents, Immunological
22
Programmed Cell Death 1 Receptor
22
pembrolizumab
21
Clinical Trial, Phase II
21
DPT0O3T46P
20
31YO63LBSN
20
Cancer Vaccines
19
Antigens, Neoplasm
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
72
2020-
179
2010-2019
21
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
251
Englisch
Haven't found what you're looking for?
Wird geladen...